| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/26/2002 | CA2441563A1 Allosteric adenosine receptor modulators |
| 09/26/2002 | CA2441155A1 Methods of treating respiratory conditions |
| 09/26/2002 | CA2441147A1 Methods of treating disorders of the eye and surrounding tissue with thymosin .beta.4 (t.beta.4), analogues, isoforms and other derivatives |
| 09/26/2002 | CA2440632A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440631A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440482A1 Tryptase-inhibitors |
| 09/26/2002 | CA2440475A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440272A1 Nucleic acid-associated proteins |
| 09/26/2002 | CA2440264A1 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient |
| 09/26/2002 | CA2436911A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors |
| 09/26/2002 | CA2403903A1 Angiogenesis inhibitors |
| 09/25/2002 | EP1243270A1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
| 09/25/2002 | EP1243263A1 Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| 09/25/2002 | EP1242455A1 N-alkylated peptides having antiangiogenic activity |
| 09/25/2002 | EP1242451A2 Compositions and methods for inhibiting endothelial cell proliferation |
| 09/25/2002 | EP1242417A1 Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents |
| 09/25/2002 | EP1242415A1 3-thiazol-4-yl-pyrrolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242407A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242404A1 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 09/25/2002 | EP1242400A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242395A1 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
| 09/25/2002 | EP1242385A1 Cytokine, especially tnf-alpha, inhibitors |
| 09/25/2002 | EP1242371A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242120A2 Combinations of growth factors and i:upa or i:mmp for the treatment of damaged tissue |
| 09/25/2002 | EP1242104A2 Process of obtaining thylakoids from plants, pure thylakoids and use thereof |
| 09/25/2002 | EP1242098A2 Aqueous ionic solutions and their uses in particular in ophthalmology |
| 09/25/2002 | EP1242096A2 Combinations for the treatment of dna viral infections comprising a loop diuretic and lithium |
| 09/25/2002 | EP1242089A2 Use of adatanserin for the treatment of neurodegenerative conditions |
| 09/25/2002 | EP1242083A1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 09/25/2002 | EP1241935A2 Methods for producing transgenic animals |
| 09/25/2002 | EP0702551B1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 09/25/2002 | CN1371424A Activatable recombinant neurotoxins |
| 09/25/2002 | CN1371359A Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
| 09/25/2002 | CN1371285A Methods and compounds for treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 09/25/2002 | CN1371275A Arificial tear replacement solution |
| 09/24/2002 | US6455674 Polypeptide for use in the diagnosis and treatment of tissue oxygenation defects |
| 09/24/2002 | US6455590 Administering a therapeutically effective amount of a deprenyl compound to a glaucoma patient |
| 09/24/2002 | US6455583 Method for treating meibomian gland disease |
| 09/24/2002 | US6455572 Estrogen agonist/antagonist metabolites |
| 09/24/2002 | US6455567 Treating dermatological disorders by administering a 3-(pyrrolidin-2-ylmethyl)-5-(aminosulfonylmethyl)indole |
| 09/24/2002 | US6455562 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/24/2002 | US6455561 Administering benzofuran derivative for therapy of disease state that is capable of being modulated by inhibition of phosphodiesterase iv or tumour necrosis factor |
| 09/24/2002 | US6455547 Method for treating pharmaceutical compositions |
| 09/24/2002 | US6455525 Heterocyclic substituted pyrazolones |
| 09/24/2002 | US6455522 Cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/20/2002 | CA2377453A1 Method of preventing retinopathy of prematurity in a neonate |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072608A2 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS |
| 09/19/2002 | WO2002072585A2 Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 09/19/2002 | WO2002072577A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
| 09/19/2002 | WO2002072541A2 Human grk7: new member of the human g-protein-coupled-receptor kinase family |
| 09/19/2002 | WO2002072105A2 Improved prostanoid therapies for the treatment of glaucoma |
| 09/19/2002 | WO2002072011A2 Stabilized therapeutic and imaging agents |
| 09/19/2002 | WO2002072003A2 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour |
| 09/19/2002 | WO2002071874A2 Composition improving age-related physiological deficits and increasing longevity |
| 09/19/2002 | WO2002053534A8 Vla-4 inhibitors |
| 09/19/2002 | WO2002050070A3 Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists |
| 09/19/2002 | WO2002049624A3 Novel pharmaceutical compositions based on anticholinergic agents and dopamine agonists |
| 09/19/2002 | WO2002014311A3 Urea compounds and methods of uses |
| 09/19/2002 | WO2002010192A3 Somatostatin analogues |
| 09/19/2002 | WO2001083729A3 Vectors for ocular transduction and use thereof for genetic therapy |
| 09/19/2002 | WO2001072702A3 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/19/2002 | WO2001064949A3 Diagnostics and therapeutics for glaucoma |
| 09/19/2002 | US20020133023 Antitumor agents, osteoporosis |
| 09/19/2002 | US20020133018 Calcium channel blockers; cardiovascular disorders; side effect reduction |
| 09/19/2002 | US20020132853 Diaryl piperazines and related compounds useful in the treatment of a chronic and acute pain conditions, itch and urinary incontinence. |
| 09/19/2002 | US20020132852 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 09/19/2002 | US20020132849 2-Amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 09/19/2002 | US20020132842 Substituted benzimidazoles, processes for their preparation, their use as medicaments, and medicaments comprising them |
| 09/19/2002 | US20020132822 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 09/19/2002 | US20020132810 Novel heterocyclic amide derivatives |
| 09/19/2002 | US20020132796 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid. |
| 09/19/2002 | US20020131966 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/19/2002 | CA2440973A1 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour |
| 09/19/2002 | CA2440618A1 Immunoglobulin superfamily proteins |
| 09/19/2002 | CA2439953A1 Stabilized therapeutic and imaging agents |
| 09/19/2002 | CA2437958A1 Polymeric immunoglobulin fusion proteins that target low-affinity fc.gamma.receptors |
| 09/18/2002 | EP1241254A1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 09/18/2002 | EP1241170A2 Pyrazolopyrimidine derivatives |
| 09/18/2002 | EP1240329A2 i STREPTOCOCCUS PNEUMONIAE /i ANTIGENS |
| 09/18/2002 | EP1240313A2 Homologues of human heparanase and splice variants thereof |
| 09/18/2002 | EP1240197A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1240194A2 Novel human protein kinases and protein kinase-like enzymes |
| 09/18/2002 | EP1240158A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 09/18/2002 | EP1240152A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
| 09/18/2002 | EP1239870A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1239854A1 Use of a hypoglycemic agent for treating impaired glucose metabolism |
| 09/18/2002 | EP1239845A2 Hydroxide-releasing agents as skin permeation enhancers |
| 09/18/2002 | EP1117633B1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 09/18/2002 | EP0934259B1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/18/2002 | EP0904260B1 Inhibition of matrix metalloproteases by 2-(omega-aroylalkyl)-4-biaryl-oxobutyric acids |
| 09/18/2002 | EP0823889B1 1,3-propane diol derivatives as bioactive compounds |
| 09/18/2002 | CN1370175A Dithiepino [6,5-b] pyridines, and related compsns. and methods |
| 09/18/2002 | CN1370173A Isomeric fused pyrrolocarbazoles and isoindolones |
| 09/18/2002 | CN1370163A Imidazo [1,2-A] pyridine and pyrazolo [2,3-a] pyridine derivatives |
| 09/18/2002 | CN1370159A Indole derivatives and their use for treatment of osteoporosis amongst other applications |
| 09/18/2002 | CN1370154A Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/18/2002 | CN1370152A 5-cyano-2-aminopyrimidine derivatives |